Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 7;84(21):4059-4078.e10.
doi: 10.1016/j.molcel.2024.10.006. Epub 2024 Oct 30.

Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome

Subhendu K Das  1 , Sharmistha Karmakar  2 , Harish Venkatachalapathy  3 , Rajiv Kumar Jha  1 , Eric Batchelor  3 , David Levens  4
Affiliations

Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome

Subhendu K Das et al. Mol Cell. .

Abstract

Hyperproliferation driven by the protooncogene MYC may lead to tumor suppressor p53 activating DNA damage that has been presumed to derive from hypertranscription and over-replication. Here, we report that excessive MYC-topoisome (MYC/topoisomerase 1/topoisomerase 2) activity acutely damages DNA-activating pATM and p53. In turn, MYC is shut off and degraded, releasing TOP1 and TOP2A from MYC topoisomes in vitro and in vivo. To manage the topological and torsional stress generated at its target genes, p53 assembles a separate topoisome. Because topoisomerase activity is intrinsically DNA damaging, p53 topoisomes provoke an initial burst of DNA damage. Because p53, unlike MYC, upregulates the DNA-damage response (DDR) and activates tyrosyl-DNA-phosphodiesterase (TDP) 1 and TDP2, it suppresses further topoisome-mediated damage. The physical coupling and activation of TOP1 and TOP2 by p53 creates a tool that supports p53-target expression while braking MYC-driven proliferation in mammalian cells.

Keywords: DNA damage; DNA repair; MYC-topoisome; p53; supercoiling; topoisomerase.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Dang CV (2012). MYC on the path to cancer. Cell 149, 22–35. 10.1016/j.cell.2012.03.003. - DOI - PMC - PubMed
    1. Hermeking H, and Eick D (1994). Mediation of c-Myc-Induced Apoptosis by p53. Science 265, 2091–3. 10.1126/science.8091232. - DOI - PubMed
    1. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, and Hancock DC (1992). Induction of Apoptosis in Fibroblasts by c-myc Protein. Cell 69, 119–28. 10.1016/0092-8674(92)90123-t. - DOI - PubMed
    1. Evan G, and Littlewood T (1998). A Matter of Life and Cell Death. Science 281, 1317–22. 10.1126/science.281.5381.1317. - DOI - PubMed
    1. Nie Z, Guo C, Das SK, Chow CC, Batchelor E, Simons Jnr SS, and Levens D (2020). Dissecting transcriptional amplification by MYC. Elife 9, 1–32. 10.7554/eLife.52483. - DOI - PMC - PubMed

MeSH terms